25 XP   0   0   10

Soleno Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Soleno together

PenkeI guess you are interested in Soleno Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Soleno Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Soleno Therapeutics Inc

I send you an email if I find something interesting about Soleno Therapeutics Inc.

Quick analysis of Soleno (30 sec.)










What can you expect buying and holding a share of Soleno? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.57
Expected worth in 1 year
$8.83
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$4.25
Return On Investment
9.9%

For what price can you sell your share?

Current Price per Share
$42.80
Expected price per share
$35.70 - $45.55
How sure are you?
50%

1. Valuation of Soleno (5 min.)




Live pricePrice per Share (EOD)

$42.80

Intrinsic Value Per Share

$-7.90 - $-3.71

Total Value Per Share

$-3.33 - $0.86

2. Growth of Soleno (5 min.)




Is Soleno growing?

Current yearPrevious yearGrowGrow %
How rich?$157.5m$18m$30.8m63.1%

How much money is Soleno making?

Current yearPrevious yearGrowGrow %
Making money-$9.7m-$5.4m-$4.2m-44.1%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Soleno (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#303 / 1031

Most Revenue
#857 / 1031

Most Profit
#584 / 1031

Most Efficient
#311 / 1031

What can you expect buying and holding a share of Soleno? (5 min.)

Welcome investor! Soleno's management wants to use your money to grow the business. In return you get a share of Soleno.

What can you expect buying and holding a share of Soleno?

First you should know what it really means to hold a share of Soleno. And how you can make/lose money.

Speculation

The Price per Share of Soleno is $42.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Soleno.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Soleno, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.57. Based on the TTM, the Book Value Change Per Share is $1.06 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Soleno.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.33-0.8%-0.30-0.7%-0.19-0.4%-0.23-0.5%-0.18-0.4%
Usd Book Value Change Per Share3.869.0%1.062.5%-0.06-0.1%0.180.4%0.140.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share3.869.0%1.062.5%-0.06-0.1%0.180.4%0.140.3%
Usd Price Per Share40.25-19.05-1.01-5.12-3.31-
Price to Earnings Ratio-30.68--14.73--1.42--3.74--2.26-
Price-to-Total Gains Ratio10.43-26.10--6.00-79.04-38.34-
Price to Book Ratio8.80-21.90-2.59-6.71-2.92-
Price-to-Total Gains Ratio10.43-26.10--6.00-79.04-38.34-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share42.8
Number of shares23
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share1.060.18
Usd Total Gains Per Share1.060.18
Gains per Quarter (23 shares)24.464.18
Gains per Year (23 shares)97.8516.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1098880177
2019618603324
3029428405041
4039138206758
5048948008475
60587578010092
706856760117109
807837740134126
908818720151143
1009799700167160

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%3.037.00.07.5%4.040.01.08.9%
Book Value Change Per Share3.01.00.075.0%4.08.00.033.3%7.013.00.035.0%16.023.01.040.0%16.025.04.035.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.045.00.0%
Total Gains per Share3.01.00.075.0%4.08.00.033.3%7.013.00.035.0%16.023.01.040.0%16.025.04.035.6%

Fundamentals of Soleno

About Soleno Therapeutics Inc

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Fundamental data was last updated by Penke on 2024-03-22 04:02:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Soleno Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Soleno earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Soleno to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Soleno Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-11,225.4%+11,225.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM--202.3%+202.3%
YOY--263.0%+263.0%
5Y--452.4%+452.4%
10Y-11,225.4%-589.0%-10,636.4%
1.1.2. Return on Assets

Shows how efficient Soleno is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Soleno to the Biotechnology industry mean.
  • -6.3% Return on Assets means that Soleno generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Soleno Therapeutics Inc:

  • The MRQ is -6.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-23.4%+17.1%
TTM-23.4%YOY-16.1%-7.3%
TTM-23.4%5Y-17.5%-5.9%
5Y-17.5%10Y-31.0%+13.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.3%-12.5%+6.2%
TTM-23.4%-12.2%-11.2%
YOY-16.1%-11.2%-4.9%
5Y-17.5%-13.3%-4.2%
10Y-31.0%-14.6%-16.4%
1.1.3. Return on Equity

Shows how efficient Soleno is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Soleno to the Biotechnology industry mean.
  • -7.2% Return on Equity means Soleno generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Soleno Therapeutics Inc:

  • The MRQ is -7.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -109.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.2%TTM-109.6%+102.5%
TTM-109.6%YOY-32.8%-76.9%
TTM-109.6%5Y-49.1%-60.5%
5Y-49.1%10Y-38.2%-10.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.2%-16.0%+8.8%
TTM-109.6%-15.8%-93.8%
YOY-32.8%-13.9%-18.9%
5Y-49.1%-18.2%-30.9%
10Y-38.2%-19.1%-19.1%

1.2. Operating Efficiency of Soleno Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Soleno is operating .

  • Measures how much profit Soleno makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Soleno to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Soleno Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-9,433.1%+9,433.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM--208.5%+208.5%
YOY--280.2%+280.2%
5Y--459.9%+459.9%
10Y-9,433.1%-596.9%-8,836.2%
1.2.2. Operating Ratio

Measures how efficient Soleno is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Soleno Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y86.901-86.901
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM-3.181-3.181
YOY-3.609-3.609
5Y-5.554-5.554
10Y86.9017.396+79.505

1.3. Liquidity of Soleno Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Soleno is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 14.89 means the company has $14.89 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Soleno Therapeutics Inc:

  • The MRQ is 14.894. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.063. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ14.894TTM5.063+9.832
TTM5.063YOY3.119+1.944
TTM5.0635Y4.631+0.432
5Y4.63110Y4.597+0.034
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.8943.987+10.907
TTM5.0634.440+0.623
YOY3.1195.569-2.450
5Y4.6316.158-1.527
10Y4.5976.492-1.895
1.3.2. Quick Ratio

Measures if Soleno is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Soleno to the Biotechnology industry mean.
  • A Quick Ratio of 14.75 means the company can pay off $14.75 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Soleno Therapeutics Inc:

  • The MRQ is 14.748. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.943. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ14.748TTM4.943+9.805
TTM4.943YOY2.992+1.951
TTM4.9435Y4.542+0.401
5Y4.54210Y4.376+0.166
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.7483.653+11.095
TTM4.9434.158+0.785
YOY2.9925.515-2.523
5Y4.5426.012-1.470
10Y4.3766.206-1.830

1.4. Solvency of Soleno Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Soleno assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Soleno to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.13 means that Soleno assets are financed with 12.8% credit (debt) and the remaining percentage (100% - 12.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Soleno Therapeutics Inc:

  • The MRQ is 0.128. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.557. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.128TTM0.557-0.428
TTM0.557YOY0.490+0.066
TTM0.5575Y0.484+0.072
5Y0.48410Y2.645-2.160
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1280.336-0.208
TTM0.5570.330+0.227
YOY0.4900.267+0.223
5Y0.4840.367+0.117
10Y2.6450.378+2.267
1.4.2. Debt to Equity Ratio

Measures if Soleno is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Soleno to the Biotechnology industry mean.
  • A Debt to Equity ratio of 14.7% means that company has $0.15 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Soleno Therapeutics Inc:

  • The MRQ is 0.147. The company is very able to pay all its debts with equity. +2
  • The TTM is 2.444. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ0.147TTM2.444-2.297
TTM2.444YOY1.022+1.422
TTM2.4445Y1.278+1.166
5Y1.27810Y0.849+0.429
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1470.376-0.229
TTM2.4440.398+2.046
YOY1.0220.334+0.688
5Y1.2780.431+0.847
10Y0.8490.476+0.373

2. Market Valuation of Soleno Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Soleno generates.

  • Above 15 is considered overpriced but always compare Soleno to the Biotechnology industry mean.
  • A PE ratio of -30.68 means the investor is paying $-30.68 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Soleno Therapeutics Inc:

  • The EOD is -32.625. Based on the earnings, the company is expensive. -2
  • The MRQ is -30.681. Based on the earnings, the company is expensive. -2
  • The TTM is -14.729. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-32.625MRQ-30.681-1.944
MRQ-30.681TTM-14.729-15.952
TTM-14.729YOY-1.420-13.309
TTM-14.7295Y-3.744-10.985
5Y-3.74410Y-2.258-1.486
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-32.625-2.697-29.928
MRQ-30.681-2.422-28.259
TTM-14.729-2.709-12.020
YOY-1.420-4.116+2.696
5Y-3.744-6.257+2.513
10Y-2.258-6.478+4.220
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Soleno Therapeutics Inc:

  • The EOD is -58.367. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -54.889. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -25.386. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-58.367MRQ-54.889-3.477
MRQ-54.889TTM-25.386-29.503
TTM-25.386YOY-1.659-23.727
TTM-25.3865Y-7.097-18.289
5Y-7.09710Y-5.801-1.296
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-58.367-3.344-55.023
MRQ-54.889-2.939-51.950
TTM-25.386-3.486-21.900
YOY-1.659-5.592+3.933
5Y-7.097-8.464+1.367
10Y-5.801-8.872+3.071
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Soleno is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 8.80 means the investor is paying $8.80 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Soleno Therapeutics Inc:

  • The EOD is 9.359. Based on the equity, the company is overpriced. -1
  • The MRQ is 8.801. Based on the equity, the company is overpriced. -1
  • The TTM is 21.896. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD9.359MRQ8.801+0.558
MRQ8.801TTM21.896-13.095
TTM21.896YOY2.587+19.310
TTM21.8965Y6.708+15.188
5Y6.70810Y2.915+3.793
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD9.3592.198+7.161
MRQ8.8012.042+6.759
TTM21.8962.121+19.775
YOY2.5872.907-0.320
5Y6.7083.682+3.026
10Y2.9154.114-1.199
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Soleno Therapeutics Inc.

3.1. Institutions holding Soleno Therapeutics Inc

Institutions are holding 97.151% of the shares of Soleno Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vivo Capital, LLC27.600927.742684180935215000162.8114
2023-12-31Nantahala Capital Management, LLC18.73066.8774571270253202981355.8216
2023-12-31Perceptive Advisors LLC10.08072.7623307454200
2023-12-31The Carlyle Group Inc9.375.5327285780456424224.6011
2023-12-31HHG PLC8.27520.0606252389731984414.5116
2023-12-31Adage Capital Partners Gp LLC5.98970.1522182681449981437.665
2023-12-31Vestal Point Capital LP4.26245.5431130000013000000
2023-12-31Vanguard Group Inc3.17920.00099696229143711654.9402
2023-12-31Balyasny Asset Management LLC3.0390.0701926876468053102.0117
2023-12-31venBio Select Advisor LLC2.57380.43647850007850000
2023-12-31COMMODORE CAPITAL LP2.29512.4619700000-187500-21.1268
2023-12-31Ikarian Capital, LLC1.93532.2245590243535239.9722
2023-12-31State Street Corporation1.6440.0015014024859543145.7405
2023-12-31BlackRock Inc1.02840.0003313661313408123876.6798
2023-12-31Ally Bridge Group (NY) LLC1.01637.43363099503099500
2023-12-31Samlyn Capital, LLC0.98950.24183017773017770
2023-12-31Emerald Advisers, LLC0.82670.434425215334791.399
2023-12-31Wellington Management Company LLP0.69710.00162126062126060
2023-12-31Emerald Mutual Fund Advisers Trust0.66010.429120132600
2023-12-31Woodline Partners LP0.65580.0875200000-63860-24.2022
Total 104.849862.49431978468+16815959+52.6%

3.2. Funds holding Soleno Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.27120.002269270000
2023-12-31Janus Henderson Triton D1.98290.35760476510457820.9078
2023-12-31Janus Henderson US SMID Cap Growth1.98290.358560476510457820.9078
2024-02-29SPDR® S&P Biotech ETF1.59880.297648763691201.9059
2024-01-31Janus Henderson Glb Life Scn I2 USD1.0120.3753086669489244.3889
2023-12-31Janus Henderson Global Life Sciences D0.92170.22992810992689410.5797
2023-12-31Janus Henderson Global Life Sciences0.92170.2312810992689410.5797
2023-12-31Janus Henderson Venture D0.90470.36192759215814026.6965
2023-12-31Janus Henderson US Small Cap Growth0.90470.36432759215814026.6965
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.74190.0107226287-220-0.0971
2023-12-31Janus Selection Global Life Science AUSD0.70090.2327213774173828.8507
2024-01-31Emerald Growth A0.35410.552710798300
2024-01-31Janus Henderson Hrzn Biotec E2 USD0.31182.0064951091679121.4395
2024-01-31Fidelity Extended Market Index0.27340.0108833848921.0813
2024-01-31Principal SmallCap Growth I Instl0.23180.14137069600
2024-02-29Direxion Daily S&P Biotech Bull 3X ETF0.14630.17084462100
2023-12-31Empower Small Cap Growth/Emerald SP0.11820.44473606100
2023-12-31BlackRock Extended Equity Market K0.10370.0092316363144916817.6471
2024-01-31APO Medical Opportunities R0.09840.16913000000
2024-01-31Fidelity Total Market Index0.09130.001527843-1361-4.6603
Total 15.67246.32734779966+548169+11.5%

3.3. Insider Transactions

Insiders are holding 2.152% of the shares of Soleno Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-25Kristen YenSELL39748.3
2024-01-25Bhatnagar AnishSELL252748.3
2023-12-13Kristen YenSELL1791637.76
2023-12-11Bhatnagar AnishSELL9340835.67
2023-12-11James H MackanessSELL3248236.41
2023-11-30Bhatnagar AnishSELL2771628.65
2023-11-30James H MackanessSELL418628.65
2023-11-29Kristen YenSELL397927.83
2023-11-28James H MackanessSELL387827.12
2023-11-28Bhatnagar AnishSELL2567827.12
2023-09-28Perceptive Advisors LlcBUY25000020
2023-09-26Perceptive Advisors LlcBUY61678916.4
2023-06-05Perceptive Advisors LlcBUY784685.98
2023-06-01Perceptive Advisors LlcBUY75005.59
2023-05-30Perceptive Advisors LlcBUY175005.34
2023-05-26Perceptive Advisors LlcBUY225005.27
2023-05-24Perceptive Advisors LlcBUY250005.48
2023-05-22Perceptive Advisors LlcBUY273005.12
2023-05-19Perceptive Advisors LlcBUY252004.62

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Soleno Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.8581.064+263%-0.057+101%0.182+2022%0.143+2589%
Book Value Per Share--4.5731.438+218%0.557+721%0.907+404%0.502+812%
Current Ratio--14.8945.063+194%3.119+378%4.631+222%4.597+224%
Debt To Asset Ratio--0.1280.557-77%0.490-74%0.484-74%2.645-95%
Debt To Equity Ratio--0.1472.444-94%1.022-86%1.278-88%0.849-83%
Dividend Per Share----0%-0%-0%-0%
Eps---0.328-0.295-10%-0.185-43%-0.229-30%-0.176-46%
Free Cash Flow Per Share---0.183-0.189+3%-0.160-13%-0.178-3%-0.154-16%
Free Cash Flow To Equity Per Share--3.4041.274+167%-0.158+105%0.289+1076%0.162+1998%
Gross Profit Margin--1.0431.011+3%1.000+4%1.002+4%1.018+2%
Intrinsic Value_10Y_max---3.711--------
Intrinsic Value_10Y_min---7.903--------
Intrinsic Value_1Y_max---0.580--------
Intrinsic Value_1Y_min---0.763--------
Intrinsic Value_3Y_max---1.585--------
Intrinsic Value_3Y_min---2.331--------
Intrinsic Value_5Y_max---2.398--------
Intrinsic Value_5Y_min---3.930--------
Market Cap1389313680.000+0%1386279270.250638228308.563+117%32930467.185+4110%170059330.885+715%109597957.461+1165%
Net Profit Margin----0%-0%-0%-112.2540%
Operating Margin----0%-0%-0%-94.3310%
Operating Ratio----0%-0%-0%86.901-100%
Pb Ratio9.359+6%8.80121.896-60%2.587+240%6.708+31%2.915+202%
Pe Ratio-32.625-6%-30.681-14.729-52%-1.420-95%-3.744-88%-2.258-93%
Price Per Share42.800+6%40.25019.048+111%1.014+3868%5.116+687%3.315+1114%
Price To Free Cash Flow Ratio-58.367-6%-54.889-25.386-54%-1.659-97%-7.097-87%-5.801-89%
Price To Total Gains Ratio11.094+6%10.43326.099-60%-6.000+158%79.038-87%38.343-73%
Quick Ratio--14.7484.943+198%2.992+393%4.542+225%4.376+237%
Return On Assets---0.063-0.234+274%-0.161+157%-0.175+180%-0.310+396%
Return On Equity---0.072-1.096+1429%-0.328+357%-0.491+585%-0.382+433%
Total Gains Per Share--3.8581.064+263%-0.057+101%0.182+2022%0.143+2589%
Usd Book Value--157507000.00048948000.000+222%18079250.000+771%29881350.000+427%16506448.800+854%
Usd Book Value Change Per Share--3.8581.064+263%-0.057+101%0.182+2022%0.143+2589%
Usd Book Value Per Share--4.5731.438+218%0.557+721%0.907+404%0.502+812%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.328-0.295-10%-0.185-43%-0.229-30%-0.176-46%
Usd Free Cash Flow---6314000.000-6235000.000-1%-5200250.000-18%-5808000.000-8%-4997215.350-21%
Usd Free Cash Flow Per Share---0.183-0.189+3%-0.160-13%-0.178-3%-0.154-16%
Usd Free Cash Flow To Equity Per Share--3.4041.274+167%-0.158+105%0.289+1076%0.162+1998%
Usd Market Cap1389313680.000+0%1386279270.250638228308.563+117%32930467.185+4110%170059330.885+715%109597957.461+1165%
Usd Price Per Share42.800+6%40.25019.048+111%1.014+3868%5.116+687%3.315+1114%
Usd Profit---11296000.000-9745750.000-14%-5448750.000-52%-7355050.000-35%-5493724.700-51%
Usd Revenue----0%-0%-0%18414959.100-100%
Usd Total Gains Per Share--3.8581.064+263%-0.057+101%0.182+2022%0.143+2589%
 EOD+6 -2MRQTTM+24 -6YOY+22 -85Y+21 -910Y+22 -10

4.2. Fundamental Score

Let's check the fundamental score of Soleno Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-32.625
Price to Book Ratio (EOD)Between0-19.359
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than114.748
Current Ratio (MRQ)Greater than114.894
Debt to Asset Ratio (MRQ)Less than10.128
Debt to Equity Ratio (MRQ)Less than10.147
Return on Equity (MRQ)Greater than0.15-0.072
Return on Assets (MRQ)Greater than0.05-0.063
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Soleno Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.937
Ma 20Greater thanMa 5044.112
Ma 50Greater thanMa 10046.275
Ma 100Greater thanMa 20039.698
OpenGreater thanClose43.440
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets180,691
Total Liabilities23,184
Total Stockholder Equity157,507
 As reported
Total Liabilities 23,184
Total Stockholder Equity+ 157,507
Total Assets = 180,691

Assets

Total Assets180,691
Total Current Assets171,358
Long-term Assets9,333
Total Current Assets
Cash And Cash Equivalents 169,681
Other Current Assets 1,677
Total Current Assets  (as reported)171,358
Total Current Assets  (calculated)171,358
+/-0
Long-term Assets
Property Plant Equipment 419
Intangible Assets 8,749
Long-term Assets Other 165
Long-term Assets  (as reported)9,333
Long-term Assets  (calculated)9,333
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities11,505
Long-term Liabilities11,679
Total Stockholder Equity157,507
Total Current Liabilities
Short-term Debt 273
Accounts payable 3,149
Other Current Liabilities 8,083
Total Current Liabilities  (as reported)11,505
Total Current Liabilities  (calculated)11,505
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt130
Long-term Liabilities Other 11,549
Long-term Liabilities  (as reported)11,679
Long-term Liabilities  (calculated)11,679
+/-0
Total Stockholder Equity
Common Stock32
Retained Earnings -276,410
Other Stockholders Equity 433,885
Total Stockholder Equity (as reported)157,507
Total Stockholder Equity (calculated)157,507
+/-0
Other
Capital Stock32
Cash and Short Term Investments 169,681
Common Stock Shares Outstanding 34,442
Liabilities and Stockholders Equity 180,691
Net Debt -169,278
Net Invested Capital 157,507
Net Working Capital 159,853
Property Plant and Equipment Gross 508
Short Long Term Debt Total 403



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
2,514
0
0
0
1,587
1,031
2,154
1,696
8,396
10,067
8,770
7,288
8,201
9,390
5,535
8,309
5,565
33,865
30,381
26,382
39,022
39,022
33,344
30,835
43,151
38,867
34,134
28,725
38,172
32,113
78,859
71,784
64,982
56,706
48,778
42,565
35,553
42,546
36,861
31,979
26,497
19,535
30,944
63,548
180,691
180,69163,54830,94419,53526,49731,97936,86142,54635,55342,56548,77856,70664,98271,78478,85932,11338,17228,72534,13438,86743,15130,83533,34439,02239,02226,38230,38133,8655,5658,3095,5359,3908,2017,2888,77010,0678,3961,6962,1541,0311,5870002,514
   > Total Current Assets 
0
0
0
0
1,524
987
1,431
307
8,338
10,023
8,165
5,526
6,404
7,583
3,756
6,507
3,801
11,800
10,318
6,390
17,994
17,994
13,311
11,413
24,670
20,865
16,615
11,609
21,144
15,642
63,004
56,485
50,243
42,528
34,544
28,887
22,422
29,978
24,889
20,572
15,647
9,127
20,498
53,659
171,358
171,35853,65920,4989,12715,64720,57224,88929,97822,42228,88734,54442,52850,24356,48563,00415,64221,14411,60916,61520,86524,67011,41313,31117,99417,9946,39010,31811,8003,8016,5073,7567,5836,4045,5268,16510,0238,3383071,4319871,5240000
       Cash And Cash Equivalents 
2,155
0
0
0
1,269
764
1,208
64
7,957
9,529
7,530
4,720
5,495
6,492
2,502
5,415
2,726
10,539
7,547
5,647
17,100
17,100
12,593
10,239
23,099
19,402
15,503
11,225
20,733
15,070
62,499
56,137
49,224
41,607
33,596
28,185
21,304
28,974
24,065
19,751
14,602
7,874
19,368
52,437
169,681
169,68152,43719,3687,87414,60219,75124,06528,97421,30428,18533,59641,60749,22456,13762,49915,07020,73311,22515,50319,40223,09910,23912,59317,10017,1005,6477,54710,5392,7265,4152,5026,4925,4954,7207,5309,5297,957641,2087641,2690002,155
       Short-term Investments 
20
0
0
0
20
0
20
20
20
20
35
111
35
35
35
35
35
35
35
35
35
35
0
0
978
788
623
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000006237889780035353535353535353535111352020202002000020
       Net Receivables 
0
0
0
0
150
41
18
37
0
8
12
94
156
187
288
137
133
110
3
0
0
0
0
0
64
72
18
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000091872640000031101331372881871569412803718411500000
       Inventory 
0
0
0
0
0
0
0
0
109
206
277
376
551
653
774
703
660
855
164
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000016485566070377465355137627720610900000000
   > Long-term Assets 
0
0
0
0
63
44
722
1,389
58
44
605
1,762
1,797
1,807
1,779
1,802
1,764
22,065
20,063
19,992
21,028
21,028
20,033
19,422
18,481
18,002
17,519
17,116
17,028
16,471
15,855
15,299
14,739
14,178
14,234
13,678
13,131
12,568
11,972
11,407
10,850
10,408
10,446
9,889
9,333
9,3339,88910,44610,40810,85011,40711,97212,56813,13113,67814,23414,17814,73915,29915,85516,47117,02817,11617,51918,00218,48119,42220,03321,02821,02819,99220,06322,0651,7641,8021,7791,8071,7971,76260544581,38972244630000
       Property Plant Equipment 
105
0
0
0
63
44
41
36
58
44
43
98
86
121
118
116
103
93
53
55
23
23
13
14
12
19
22
46
444
373
302
232
158
83
585
515
454
377
307
229
157
75
560
489
419
41948956075157229307377454515585831582323023734444622191214132323555393103116118121869843445836414463000105
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
718
718
718
718
718
718
718
0
0
126
126
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001261260071871871871871871871800000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
562
946
917
892
867
842
817
21,128
19,884
19,353
20,413
20,413
19,441
18,955
18,469
17,983
17,497
17,011
16,525
16,039
15,553
15,067
14,581
14,095
13,609
13,123
12,637
12,151
11,665
11,178
10,693
10,207
9,721
9,235
8,749
8,7499,2359,72110,20710,69311,17811,66512,15112,63713,12313,60914,09514,58115,06715,55316,03916,52517,01117,49717,98318,46918,95519,44120,41320,41319,35319,88421,1288178428678929179465620000000000
       Long-term Assets Other 
0
0
0
0
0
0
681
1,353
0
0
0
0
76
76
76
126
126
126
126
584
592
592
579
453
0
18,002
17,519
59
59
59
285
212
139
63
40
40
40
40
279
0
0
126
165
165
165
16516516512600279404040406313921228559595917,51918,002045357959259258412612612612676767600001,353681000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
1,353
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000001,3530000000
> Total Liabilities 
12,902
0
0
0
39,451
39,718
42,281
44,074
18,729
21,370
16,402
8,579
4,977
3,556
2,925
2,597
2,130
3,721
3,693
3,172
12,487
12,487
17,507
16,630
12,738
15,236
20,291
13,840
23,225
22,632
22,682
23,778
19,435
19,138
21,341
22,362
17,760
16,085
16,553
16,779
16,149
16,896
18,518
40,328
23,184
23,18440,32818,51816,89616,14916,77916,55316,08517,76022,36221,34119,13819,43523,77822,68222,63223,22513,84020,29115,23612,73816,63017,50712,48712,4873,1723,6933,7212,1302,5972,9253,5564,9778,57916,40221,37018,72944,07442,28139,71839,45100012,902
   > Total Current Liabilities 
11,542
0
0
0
14,178
14,691
986
1,596
1,290
1,059
13,349
6,028
3,193
2,579
1,901
1,777
1,707
2,172
2,122
1,731
1,733
1,733
1,945
2,508
1,877
2,250
2,855
3,454
4,964
7,287
8,363
7,996
8,618
9,509
8,362
9,042
8,007
7,313
7,246
7,342
7,313
7,761
8,798
28,993
11,505
11,50528,9938,7987,7617,3137,3427,2467,3138,0079,0428,3629,5098,6187,9968,3637,2874,9643,4542,8552,2501,8772,5081,9451,7331,7331,7312,1222,1721,7071,7771,9012,5793,1936,02813,3491,0591,2901,59698614,69114,17800011,542
       Short-term Debt 
0
0
0
0
13,992
14,379
0
0
102
102
11,025
3,851
865
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
305
315
298
220
139
57
180
290
282
344
337
239
155
39
212
256
273
27325621239155239337344282290180571392202983153050000000000000008653,85111,0251021020014,37913,9920000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
102
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000010200000000
       Accounts payable 
220
0
0
0
58
89
639
1,238
987
621
989
953
695
1,262
957
862
538
935
1,029
642
1,606
633
981
1,245
934
1,258
1,740
1,735
1,995
3,480
3,657
3,213
3,489
4,669
3,348
3,858
3,254
2,411
2,406
2,324
1,777
2,778
3,442
3,216
3,149
3,1493,2163,4422,7781,7772,3242,4062,4113,2543,8583,3484,6693,4893,2133,6573,4801,9951,7351,7401,2589341,2459816331,6066421,0299355388629571,2626959539896219871,2386398958000220
       Other Current Liabilities 
191
0
0
0
14,121
14,602
346
358
201
438
12,360
5,075
2,498
1,317
944
915
1,169
1,237
1,093
1,089
127
1,100
964
1,263
943
992
1,115
1,719
382
308
444
408
196
232
255
492
323
4,558
4,503
4,779
5,381
4,944
513
20,786
8,083
8,08320,7865134,9445,3814,7794,5034,5583234922552321964084443083821,7191,1159929431,2639641,1001271,0891,0931,2371,1699159441,3172,4985,07512,36043820135834614,60214,121000191
   > Long-term Liabilities 
0
0
0
0
25,273
25,027
41,296
42,478
17,439
20,311
3,053
2,551
1,785
977
1,024
820
422
1,549
1,571
1,441
10,754
10,754
15,562
14,122
10,861
12,986
17,436
10,386
18,261
15,345
14,319
15,782
10,817
9,629
12,979
13,320
9,753
8,772
9,307
9,437
8,836
9,135
9,720
11,335
11,679
11,67911,3359,7209,1358,8369,4379,3078,7729,75313,32012,9799,62910,81715,78214,31915,34518,26110,38617,43612,98610,86114,12215,56210,75410,7541,4411,5711,5494228201,0249771,7852,5513,05320,31117,43942,47841,29625,02725,2730000
       Long term Debt Total 
0
0
0
0
0
0
0
15,604
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000015,6040000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-13,992
-14,379
0
0
-102
-102
-11,025
-3,851
-865
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
372
274
175
79
0
0
0
0
273
214
130
130214273000079175274372000000000000000000000-865-3,851-11,025-102-10200-14,379-13,9920000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
1,353
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000001,3530000000
       Warrants
0
0
0
0
0
0
0
23,808
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000023,8080000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
151
109
200
200
196
0
1,201
1,132
1,132
5,320
6,148
6,506
7,421
5,649
5,855
6,038
6,104
6,085
6,582
9,364
10,138
10,278
9,291
12,325
12,876
9,547
8,689
9,305
9,437
8,835
9,134
9,447
10,468
11,549
11,54910,4689,4479,1348,8359,4379,3058,6899,54712,87612,3259,29110,27810,1389,3646,5826,0856,1046,0385,8555,6497,4216,5066,1485,3201,1321,1321,201019620020010915100000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
3,066
17,439
20,311
3,053
2,400
1,675
777
0
624
280
348
439
309
5,434
5,222
9,056
6,701
5,212
7,131
11,398
0
12,176
8,763
4,955
5,644
539
338
282
0
0
0
2
0
0
1
0
0
0
00010020002823385395,6444,9558,76312,176011,3987,1315,2126,7019,0565,2225,43430943934828062407771,6752,4003,05320,31117,4393,0660000000
> Total Stockholder Equity
0
0
0
0
-37,864
-38,687
-40,127
-42,378
-10,333
-11,303
-7,632
-1,291
3,224
5,834
2,610
5,712
3,435
30,144
26,688
23,210
26,535
26,535
15,837
14,205
30,413
23,631
13,843
14,885
14,947
9,481
56,177
48,006
45,547
37,568
27,437
20,203
17,793
26,461
20,308
15,200
10,348
2,639
12,426
23,220
157,507
157,50723,22012,4262,63910,34815,20020,30826,46117,79320,20327,43737,56845,54748,00656,1779,48114,94714,88513,84323,63130,41314,20515,83726,53526,53523,21026,68830,1443,4355,7122,6105,8343,224-1,291-7,632-11,303-10,333-42,378-40,127-38,687-37,8640000
   Retained Earnings -276,410-265,114-254,253-245,778-237,422-231,936-225,804-219,079-213,355-210,527-202,387-191,399-182,445-179,593-171,048-163,664-157,806-143,181-144,070-134,062-127,032-127,295-125,371-113,979-113,979-108,954-105,167-101,199-98,312-95,698-92,948-89,436-86,247-83,402-80,109-81,989-70,975-63,120-60,727-57,934-57,1010000
   Accumulated Other Comprehensive Income 
0
0
0
0
-155
-134
-130
-136
-145
-145
0
0
-212
-212
0
0
-159
-159
0
0
-74
-74
0
0
-93
-93
0
0
-31
-31
0
0
0
0
0
0
0
-2
-1
-2
0
16
0
-1
0
0-10160-2-1-20000000-31-3100-93-9300-74-7400-159-15900-212-21200-145-145-136-130-134-1550000
   Capital Surplus 
0
0
0
0
0
0
0
20,741
60,636
70,679
72,469
82,099
89,456
95,255
95,543
101,395
101,730
131,296
131,807
132,154
140,495
140,733
141,187
141,479
157,413
157,661
157,881
158,034
172,708
173,100
227,145
227,519
227,912
228,887
229,744
0
0
0
245,993
0
0
248,393
0
0
0
000248,39300245,993000229,744228,887227,912227,519227,145173,100172,708158,034157,881157,661157,413141,479141,187140,733140,495132,154131,807131,296101,730101,39595,54395,25589,45682,09972,46970,67960,63620,7410000000
   Treasury Stock000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-1,958
Gross Profit-1,958-1,958
 
Operating Income (+$)
Gross Profit-1,958
Operating Expense-36,712
Operating Income-38,670-38,670
 
Operating Expense (+$)
Research Development25,189
Selling General Administrative13,481
Selling And Marketing Expenses1,958
Operating Expense36,71240,628
 
Net Interest Income (+$)
Interest Income559
Interest Expense-0
Other Finance Cost-0
Net Interest Income559
 
Pretax Income (+$)
Operating Income-38,670
Net Interest Income559
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-38,988-38,352
EBIT - interestExpense = -38,670
-38,988
-38,988
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-38,670-38,988
Earnings Before Interest and Taxes (EBITDA)-36,712
 
After tax Income (+$)
Income Before Tax-38,988
Tax Provision-0
Net Income From Continuing Ops-33,178-38,988
Net Income-38,988
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses38,670
Total Other Income/Expenses Net-318-559
 

Technical Analysis of Soleno
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Soleno. The general trend of Soleno is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Soleno's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Soleno Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 45.31 < 45.45 < 45.55.

The bearish price targets are: 40.74 > 37.74 > 35.70.

Tweet this
Soleno Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Soleno Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Soleno Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Soleno Therapeutics Inc. The current macd is -1.05179186.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Soleno price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Soleno. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Soleno price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Soleno Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartSoleno Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Soleno Therapeutics Inc. The current adx is 35.94.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Soleno shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Soleno Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Soleno Therapeutics Inc. The current sar is 44.17.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Soleno Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Soleno Therapeutics Inc. The current rsi is 42.94. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Soleno Therapeutics Inc Daily Relative Strength Index (RSI) ChartSoleno Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Soleno Therapeutics Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Soleno price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Soleno Therapeutics Inc Daily Stochastic Oscillator ChartSoleno Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Soleno Therapeutics Inc. The current cci is -65.93174399.

Soleno Therapeutics Inc Daily Commodity Channel Index (CCI) ChartSoleno Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Soleno Therapeutics Inc. The current cmo is -16.40812346.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Soleno Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartSoleno Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Soleno Therapeutics Inc. The current willr is -58.37004405.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Soleno is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Soleno Therapeutics Inc Daily Williams %R ChartSoleno Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Soleno Therapeutics Inc.

Soleno Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Soleno Therapeutics Inc. The current atr is 2.35101091.

Soleno Therapeutics Inc Daily Average True Range (ATR) ChartSoleno Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Soleno Therapeutics Inc. The current obv is 159,775,708.

Soleno Therapeutics Inc Daily On-Balance Volume (OBV) ChartSoleno Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Soleno Therapeutics Inc. The current mfi is 53.82.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Soleno Therapeutics Inc Daily Money Flow Index (MFI) ChartSoleno Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Soleno Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Soleno Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Soleno Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.937
Ma 20Greater thanMa 5044.112
Ma 50Greater thanMa 10046.275
Ma 100Greater thanMa 20039.698
OpenGreater thanClose43.440
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Soleno with someone you think should read this too:
  • Are you bullish or bearish on Soleno? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Soleno? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Soleno Therapeutics Inc

I send you an email if I find something interesting about Soleno Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Soleno Therapeutics Inc.

Receive notifications about Soleno Therapeutics Inc in your mailbox!